Alimta (Pemetrexed) – Oncology Drug

Pemetrexed – Oncology Drug Information Alimta is a novel antifolate compound with inhibitory activity against a number of enzymes including thymidilate synthase, dihydrofolate reductase and glycinamide ribonucleotide formyl transferase. Alimta has been studied with cis-platinum (Cisplatin) or gemcitabine (Gemzarâ) in the treatment of non-small-cell lung cancer (NSCLC). Phase II...

Allergy Migraine Headaches

Allergic and Migraine Headaches – Allergy Migraine Headaches HEADACHES ASSOCIATED with hay fever, perennial allergic rhinitis and many of the eye allergies are common. These headaches are usually secondary to the primary allergic condition, and are cured when the primary allergy is corrected. There are certain headaches which are...

Iressa (Gefitinib)

Oncology Drug Information – Iressa has a targeted mechanism of action, which results in less severe adverse reactions, side effects compared to traditional chemotherapy. Gefitinib is an oral selective epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI). The EGFR (ErbB1, HER1) receptor is similar to Her2/neu. Activation of EGFR stimulates...